Knobbe Martens
Marko Zoretic is a seasoned legal professional currently serving as a Partner at Knobbe Martens Olson & Bear LLP since August 2003. Zoretic has held prominent leadership positions, including President of the Association of Croatian American Professionals from 2014 to 2020 and President of the Croatian American Bar Association from April 2005 to December 2012. Additionally, Zoretic was the Past President and Founder of the Canadian American Bar Association from February 2009 to December 2010. A graduate of York University - Osgoode Hall Law School with an LLB degree achieved between 2000 and 2003, and McMaster University with a degree in Engineering and Management (Electrical Engineering) from 1994 to 2000, Zoretic's tenure includes experience as a Summer Associate at Knobbe Martens in 2002 and roles at Gennum Corporation and IBM Canada prior to entering the legal field.
This person is not in any teams
This person is not in any offices
Knobbe Martens
2 followers
Our firm boasts IP law’s largest and most experienced biotechnology group, with more than 60 attorneys and scientists representing clients in all stages of their business and technology development. Our clients are innovators in a variety of disciplines including PCR, molecular tools and probes, immunology (antibodies and other binding proteins), cell varieties and uses (including stem cells) and biological polymers, to name but a few. Our expertise across the entire biotech landscape gives us great insight into specific technologies, systems and markets. More importantly, our holistic understanding of the interrelated technologies and systems typically involved in a single invention allows us to provide coordinated guidance and counsel from inception though introduction. Working in collaboration with more than 300 IP firms worldwide, we effect patent, trademark, copyright, and other filings, and direct oppositions, cancellations, and litigation matters in over 120 countries. We have considerable experience in negotiating and drafting traditional licensing agreements as well as agreements for strategic alliances, partnerships and joint ventures. We also maintain a talented litigation department adept in all aspects of biotechnology IP law, including the Biosimilars legislation. Our extensive Hatch-Waxman litigation experience combined with our understanding of the biotechnology industry uniquely positions Knobbe Martens to help clients develop and implement litigation strategies designed to maximize their place in the Biosimilars market place. In addition, we have considerable experience litigating before the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission. Our attorneys have experience in all areas of Biotechnology, including: Aesthetic & Cosmetic Biotechnology Antibodies & Immunology Biofuels Biological Manufacturing Of Chemicals Biologics Diagnostic Tools Genomics Industrial Enzymes Peptides Personalized Medicine Research Tools & Reagents Stem Cells & Regenerative Medicine Synthetic Biology & Nanotechnology Therapeutics Tissue Engineering Transgenic Animals Vaccines